Long-Term Treatment of Eosinophilic Esophagitis With Budesonide Oral Suspension

Abstract

For induction full responders, continuing BOS numerically improved maintenance of efficacy vs withdrawal. A longer therapy duration did not raise safety concerns. (ClinicalTrials.gov: NCT02736409.).